20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Cost-Effective Montelukast: Price Factors for Bulk Purchase

For pharmaceutical companies, managing costs without compromising on quality is a continuous challenge. Montelukast (CAS 158966-92-8), a crucial intermediate for asthma and allergy medications, is often procured in bulk quantities. Understanding the factors that influence its price is essential for effective budgeting and securing the best value from suppliers.

Several key elements contribute to the price of Montelukast. Firstly, the purity level is a significant determinant; higher purity grades, such as the standard 98% required for pharmaceutical applications, typically command higher prices due to more rigorous manufacturing and purification processes. The scale of purchase also plays a vital role; bulk orders generally benefit from lower per-unit costs. Manufacturers and suppliers often offer tiered pricing based on volume.

The origin of supply also impacts pricing. China, as a major global chemical manufacturing hub, often offers competitive pricing for Montelukast due to economies of scale, advanced production technologies, and potentially lower labor costs. When sourcing from Chinese manufacturers, buyers can explore various payment terms (like T/T, L/C, Paypal) and shipping Incoterms (FOB, CFR, CIF, EXW) which can also influence the final landed cost.

Furthermore, market dynamics, raw material costs, and global demand for asthma and allergy treatments can influence Montelukast pricing. Staying informed about market trends and cultivating strong relationships with reliable suppliers can provide leverage in price negotiations. Requesting multiple quotes from different manufacturers and suppliers is a standard practice to benchmark pricing and identify the most cost-effective options.

In conclusion, securing cost-effective Montelukast for bulk pharmaceutical purchase involves a strategic approach. By focusing on purity requirements, understanding volume discounts, leveraging the competitive landscape in China, and carefully managing payment and shipping terms, pharmaceutical companies can optimize their procurement process and ensure access to this vital intermediate at favorable prices.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Montelukast Intermediate: Key Specs for Pharmaceutical Buyers

Next: The Supply Chain for Montelukast: Partnering with China

All Rights Reserved